Results 201 to 210 of about 278,493 (340)

Playing Favorites with Shareholders [PDF]

open access: green, 2001
Stephen J. Choi, Eric L. Talley
openalex   +1 more source

Incentives for Partial Acquisitions and Real Market Concentration [PDF]

open access: yes
We analyze the incentives of a controlling shareholder of a firm to acquire, directly or indirectly through his firm, shares in a competitor. We charaterize the conditions under which these partial acquisitions as well as the equilibrium toehold and its ...
Marie-Cécile Fagart   +2 more
core  

Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The polymorphic CYP2D6 enzyme plays a pivotal role in the metabolism of approximately 25% of clinically prescribed drugs. However, the impact of specific genetic variants on the interindividual variability in CYP2D6‐mediated drug metabolism remains insufficiently quantified. This translational study sought to address this gap by analyzing the genotypes
Inger Johansson   +11 more
wiley   +1 more source

Corporate Social Responsibility in a Corporate Governance Framework [PDF]

open access: yes
We argue that Corporate Social Responsibility (CSR) may affect the agency relationship inside a firm. We analyze how CSR and the threat of stakeholder activism influence effort of manager and shareholder, and describe how CSR may arise endogenously in ...
Linda A. Toolsema, Yohanes E. Riyanto
core  

Use of PopPK and E‐R Analyses toward Explaining Causal Link Between ADAMTS13 in Recombinant vs. Plasma‐Based Therapies and Clinical Effects in cTTP

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra‐rare, potentially life‐threatening condition caused by a deficiency of the blood enzyme ADAMTS13. Until now, ADAMTS13 replacement has been achieved with infusions of plasma or plasma‐based therapies (PBT).
Munjal Patel   +11 more
wiley   +1 more source

The Business Case for Circular Economy: A Co‐Evolutionary Perspective for Integrating Moral Cases Into Circular Economy Business Cases

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The ongoing debate in corporate sustainability (CS) about the moral case versus the business case has recently made its way into the circular economy (CE) discourse, bringing with it new tradeoffs. Although the business case perspective emphasizes profitability, critics argue that the moral case must go beyond profit motives and include ...
Felix Carl Schultz   +2 more
wiley   +1 more source

A Hallux Valgus Surgical Planning Survey Using WBCT-based 3D Printing. [PDF]

open access: yesFoot Ankle Orthop
Lintz F   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy